| Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ... The Lancet Neurology 17 (2), 162-173, 2018 | 6794 | 2018 |
| Multiple sclerosis progression: time for a new mechanism-driven framework T Kuhlmann, M Moccia, T Coetzee, JA Cohen, J Correale, J Graves, ... The Lancet Neurology 22 (1), 78-88, 2023 | 198 | 2023 |
| Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS RJ Fox, A Thompson, D Baker, P Baneke, D Brown, P Browne, ... Multiple Sclerosis Journal 18 (11), 1534-1540, 2012 | 140 | 2012 |
| The 2013 clinical course descriptors for multiple sclerosis: a clarification FD Lublin, T Coetzee, JA Cohen, RA Marrie, AJ Thompson, ... Neurology 94 (24), 1088-1092, 2020 | 87 | 2020 |
| Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) task force on clinical disability measures D Ontaneda, N LaRocca, T Coetzee, RA Rudick Multiple Sclerosis Journal 18 (8), 1074-1080, 2012 | 82 | 2012 |
| Medicines for the mind: policy-based “pull” incentives for creating breakthrough CNS drugs DW Choi, R Armitage, LS Brady, T Coetzee, W Fisher, S Hyman, A Pande, ... Neuron 84 (3), 554-563, 2014 | 75 | 2014 |
| Atlas of MS 2020: Informing global policy change T Coetzee, AJ Thompson Multiple Sclerosis Journal 26 (14), 1807-1808, 2020 | 30 | 2020 |
| Facing the urgency of therapies for progressive MS—a Progressive MS Alliance proposal F Dangond, A Donnelly, R Hohlfeld, C Lubetzki, S Kohlhaas, L Leocani, ... Nature Reviews Neurology 17 (3), 185-192, 2021 | 23 | 2021 |
| Unified understanding of MS course is required for drug development T Coetzee, AJ Thompson Nature Reviews Neurology 14 (4), 191-192, 2018 | 20 | 2018 |
| Progressive MS alliance industry forum: maximizing collective impact to enable drug development P Zaratin, G Comi, T Coetzee, K Ramsey, K Smith, A Thompson, ... Trends in Pharmacological Sciences 37 (10), 808-810, 2016 | 19 | 2016 |
| Overcoming barriers in progressive multiple sclerosis research T Coetzee, P Zaratin, TL Gleason The Lancet Neurology 14 (2), 132-133, 2015 | 18 | 2015 |
| Pathways to cures for multiple sclerosis: A research roadmap BF Bebo Jr, M Allegretta, D Landsman, KM Zackowski, F Brabazon, ... Multiple Sclerosis Journal 28 (3), 331-345, 2022 | 14 | 2022 |
| The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions P Zaratin, P Vermersch, MP Amato, G Brichetto, T Coetzee, G Cutter, ... Multiple Sclerosis and Related Disorders 61, 103757, 2022 | 13 | 2022 |
| Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal AJ Thompson, W Carroll, O Ciccarelli, G Comi, A Cross, A Donnelly, ... Multiple Sclerosis Journal 28 (1), 16-28, 2022 | 11 | 2022 |
| Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC) D Jakimovski, KS Kavak, K Zakalik, T Coetzee, M Gottesman, PK Coyle, ... Multiple Sclerosis Journal 29 (6), 753-756, 2023 | 5 | 2023 |
| Time for a new mechanism-driven framework to define multiple sclerosis progression T Kuhlmann, M Moccia, T Coetzee, JA Cohen, J Correale, J Graves, ... The Lancet. Neurology 22 (1), 78, 2023 | 2 | 2023 |
| Sharing data from MS clinical trials: Opportunities, challenges, and future directions T Coetzee Multiple Sclerosis Journal 21 (11), 1365-1368, 2015 | 2 | 2015 |
| Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community AJ Thompson, M Moccia, MP Amato, PA Calabresi, M Finlayson, ... Multiple Sclerosis Journal 29 (11-12), 1363-1372, 2023 | 1 | 2023 |
| Data sharing goals for nonprofit funders of clinical trials T Coetzee, MP Ball, M Boutin, A Bronson, DT Dexter, RA English, ... Journal of Participatory Medicine 13 (1), e23011, 2021 | 1 | 2021 |
| Composite confirmed disability worsening is a useful clinical trial endpoint for multiple sclerosis focusing on a disability progression L Kappos, S Yiu, G Cutter, T Coetzee, U Bonati, S Yuen, F Dahlke, ... MULTIPLE SCLEROSIS JOURNAL 29, 338-339, 2023 | | 2023 |
